Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia

Yasuhiro Shirahata, Nobuhiro Ohkohchi, Naoki Kawagishi, Masaru Syouji, Sigeki Tsukamoto, Satoru Sekiguchi, Nozomisa Koyamada, Sinichi Oikawa, Susumu Satomi

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Familial hypercholesterolemia is a rare inherited disease with an incidence of approximately one per million. Severe hypercholesterolemia is observed from the time of birth onwards. It is associated with severe atherosclerosis in childhood, leading to death from myocardial infarction before the age of 20 years. Liver transplantation is the only effective treatment for this disease. We experienced the case of an infant aged 2 years 5 months who had homozygous familial hypercholesterolemia and who received a liver graft from his father, who had familial heterozygous hypercholesterolemia. The pre-operative plasma cholesterol level was > 800 mg/dl. After liver transplantation, the recipient's cholesterol level decreased to 250 mg/dl after we administered the HMG-CoA reductase inhibitor. At present, 6 months after transplantation, the patient is doing well and free from a special diet. We can thus conclude that the combination therapy of liver transplantation from a donor with heterozygous familial hypercholesterolemia on cholesterol-lowering drugs is an effective therapy for a patient with the homozygous type of hypercholesterolemia.

Original languageEnglish
Pages (from-to)276-279
Number of pages4
JournalTransplant International
Volume16
Issue number4
DOIs
Publication statusPublished - 2003 Apr 1

Keywords

  • Donor with heterozygous hypercholesterolemia
  • Homozygous familial hypercholesterolemia
  • Liver transplantation

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia'. Together they form a unique fingerprint.

  • Cite this

    Shirahata, Y., Ohkohchi, N., Kawagishi, N., Syouji, M., Tsukamoto, S., Sekiguchi, S., Koyamada, N., Oikawa, S., & Satomi, S. (2003). Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia. Transplant International, 16(4), 276-279. https://doi.org/10.1111/j.1432-2277.2003.tb00299.x